About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5992 record(s)
Req # A-2024-00001
Copy of surveillance footage at Toronto Pearson Airport (YYZ) on February 23, 2024 at approximately 11:45 am to 11:50 am.Organization: Canadian Air Transport Security Authority
April 2024
Req # A-2023-43
NRC reports on market analysis concerning rapid tests for COVID-19, also called diagnostic tests and lateral flow immunoassays.Organization: National Research Council Canada
April 2024
Req # A-2023-39
Records relating to employees requesting approval to travel abroad with their work laptops from March 2021 to present (2024-02-14), include: name of the employee, destination, travel dates, reason for travel, whether the request was approved/denied and why.Organization: National Research Council Canada
April 2024
Req # A-2023-44
All documentation submitted in support of agreement number 999609 PharmaPlanter Technologies Inc.Organization: National Research Council Canada
April 2024
Req # A-2023-25
All records regarding grants, contributions and advances of loans or other monies made to Farmers Edge Inc. 2021-present (2023-10-25).Organization: National Research Council Canada
April 2024
Req # A-2023-00004
A digital, machine-readable copy of passenger complaints at YUL (Montreal airport) from Jan. 1, 2020 to June 12, 2023Organization: Canadian Air Transport Security Authority
March 2024
Req # A-2023-08
Would you be able to send me the application forms and any further details about the following projects that Powderkeg Labs Inc / GetQuorum received funding for? Title: 1002385 Agreement Number: 1002385 Agreement Value: $1,500,000.00 Agreement Date: Apr 1, 2022 - Mar 31, 2026 Description: To market expansion plan for its digital platform by developing a targeted sales and marketing strategy for entry into the United States markets. Organization: Federal Economic Development Agency for Southern Ontario, Expected Results: To achieve one or more of the following departmental results, i) Businesses in southern Ontario invest in the development and commercialization of innovative technologies, ii) Businesses in southern Ontario are innovative and growing; and iii) Communities are economically diversified in southern Ontario.Organization: Federal Economic Development Agency for Southern Ontario
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024
Req # A-2019-001525
The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.Organization: Health Canada
March 2024